Line 1: |
Line 1: |
| Also known as '''''FeLV | | Also known as '''''FeLV |
| + | [[Image:FeLV Electron Micrograph.jpg|thumb|right|150px|FeLV Electron Micrograph [http://phil.cdc.gov/phil/home.asp Public Health Image Library] Image #5610]] |
| | | |
| ==Introduction== | | ==Introduction== |
| + | [[Image:Kinetics of FeLV 2.jpg|thumb|right|200px|Kinetics of FeLV - Copyright Dr Brian Catchpole BVetMed PhD MRCVS]] |
| + | *Oncogenic retrovirus |
| + | *Causes neoplasia (lymphoma), myelosuppression (anaemia) and immunosuppression (of [[Lymphocytes#T cells|T cells]]) |
| + | *2 strains: |
| + | **FeLV-A |
| + | ***Natural strain |
| + | **FeLV-B |
| + | ***Formed through FeLV-A recombining with endogenous retroviral sequences in the feline genome |
| + | ***Increases the risks of lymphoma |
| + | **FeLV-C |
| + | ***Formed from the spontaneous mutation of FeLV-A |
| + | ***Is more myelosuppressive |
| + | *Virus replicates in the oropharyngeal lymphoid tissue causing a viraemia (virus circulating in the bloodstream) which then spreads to the systemic lymphoid tissue |
| + | *Shed in saliva |
| + | *Passed by oronasal route, e.g. mutual grooming |
| + | *Kittens between 6 weeks and 6 months are most susceptible |
| + | *60% of cats will become immune to the disease and recover |
| + | *Cats that are persistently viraemic will progress to develop FeLV-associated diseases |
| + | *Some cats will become viraemic again if treated with corticosteroids or stressed if the infection lies dormant in the [[Bone Marrow - Anatomy & Physiology|bone marrow]] |
| | | |
| ==Pathogenesis== | | ==Pathogenesis== |
Line 54: |
Line 74: |
| ===Vaccination=== | | ===Vaccination=== |
| Ideally, this should take place once antigen-negative status has been determined by laboratory testing. '''Leukogen''' is a subunit vaccine (using envelope protein gp70) produced in ''E. coli'' mixed with Quill-A and alhydrogel. Others include inactivated virus and canarypox recombinants, but all MUST include FeLV-A. | | Ideally, this should take place once antigen-negative status has been determined by laboratory testing. '''Leukogen''' is a subunit vaccine (using envelope protein gp70) produced in ''E. coli'' mixed with Quill-A and alhydrogel. Others include inactivated virus and canarypox recombinants, but all MUST include FeLV-A. |
− |
| |
− | (FeLV)
| |
− | [[Image:FeLV Electron Micrograph.jpg|thumb|right|150px|FeLV Electron Micrograph [http://phil.cdc.gov/phil/home.asp Public Health Image Library] Image #5610]]
| |
− | [[Image:Kinetics of FeLV 2.jpg|thumb|right|150px|Kinetics of FeLV - Copyright Dr Brian Catchpole BVetMed PhD MRCVS]]
| |
− | *Oncogenic retrovirus
| |
− | *Causes neoplasia (lymphoma), myelosuppression (anaemia) and immunosuppression (of [[Lymphocytes#T cells|T cells]])
| |
− | *2 strains:
| |
− | **FeLV-A
| |
− | ***Natural strain
| |
− | **FeLV-B
| |
− | ***Formed through FeLV-A recombining with endogenous retroviral sequences in the feline genome
| |
− | ***Increases the risks of lymphoma
| |
− | **FeLV-C
| |
− | ***Formed from the spontaneous mutation of FeLV-A
| |
− | ***Is more myelosuppressive
| |
− | *Virus replicates in the oropharyngeal lymphoid tissue causing a viraemia (virus circulating in the bloodstream) which then spreads to the systemic lymphoid tissue
| |
− | *Shed in saliva
| |
− | *Passed by oronasal route, e.g. mutual grooming
| |
− | *Kittens between 6 weeks and 6 months are most susceptible
| |
− | *60% of cats will become immune to the disease and recover
| |
− | *Cats that are persistently viraemic will progress to develop FeLV-associated diseases
| |
− | *Some cats will become viraemic again if treated with corticosteroids or stressed if the infection lies dormant in the [[Bone Marrow - Anatomy & Physiology|bone marrow]]
| |
| | | |
| ==Treatment== | | ==Treatment== |
− | **Antibiotics for secondary infection
| + | Where treatment is undertaken, anti-retroviral therapy is indicated with antibiotics to control secondary infections. Prevention is a key element in the treatment of FeLV overall. |
− | **Anti-retroviral therapy
| |
− | *For vaccinations see [[Vaccines#Cat Vaccinations|here]]
| |
| | | |
| | | |
Line 86: |
Line 82: |
| | | |
| [[Category:Mammalian Type C retrovirus ]][[Category:Cat]][[Category:Secondary Immunodeficiency]] | | [[Category:Mammalian Type C retrovirus ]][[Category:Cat]][[Category:Secondary Immunodeficiency]] |
− | [[Category:To_Do_-_Clinical/Viruses]]
| + | [[Category:Lymphoreticular and Haemopoietic Diseases]] |
− | [[Category:To Do - Blood]][[Category:To Do - Clinical]][[Category:Lymphoreticular and Haemopoietic Diseases]]
| |